230 related articles for article (PubMed ID: 12737176)
1. New rules for gene-transfer trials.
Nelson RM
IRB; 2001; 23(6):11. PubMed ID: 12737176
[No Abstract] [Full Text] [Related]
2. NIH under fire over gene-therapy trials..
Wadman M
Nature; 2000 Jan; 403(6767):237. PubMed ID: 10659820
[No Abstract] [Full Text] [Related]
3. Light, fast, and flexible: a new approach to regulation of human gene therapy.
Cregan JA
McGeorge Law Rev; 2000; 32(1):261-87. PubMed ID: 15709266
[No Abstract] [Full Text] [Related]
4. Tighter watch urged on adenoviral vectors...with proposal to report all 'adverse events'.
Smaglik P
Nature; 1999 Dec; 402(6763):707. PubMed ID: 10617181
[No Abstract] [Full Text] [Related]
5. NIH panel to limit secrecy on gene therapy.
Wadman M
Nature; 1999 Nov; 402(6757):6. PubMed ID: 10573406
[No Abstract] [Full Text] [Related]
6. Protecting research subjects--what must be done.
Shalala D
N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573
[No Abstract] [Full Text] [Related]
7. Gene therapy investigations proliferate.
Hollon T
Nat Med; 2000 Mar; 6(3):235. PubMed ID: 10700200
[No Abstract] [Full Text] [Related]
8. NIH tightens up monitoring of gene-therapy mishaps.
Smaglik P
Nature; 2000 Mar; 404(6773):5. PubMed ID: 10716412
[No Abstract] [Full Text] [Related]
9. Inquiry into gene therapy widens.
Grisham J
Nat Biotechnol; 2000 Mar; 18(3):254-5. PubMed ID: 10700127
[No Abstract] [Full Text] [Related]
10. Safety panel backs principle of gene-therapy trials.
Check E
Nature; 2002 Dec; 420(6916):595. PubMed ID: 12478252
[No Abstract] [Full Text] [Related]
11. Restoring public trust in gene therapy.
Kennedy EM
J Biolaw Bus; 2001; 4(3):3-4. PubMed ID: 12962103
[No Abstract] [Full Text] [Related]
12. Gene therapy approval may be rocky road for industry.
Gavaghan H
Nature; 1995 Mar; 374(6519):202. PubMed ID: 7885431
[No Abstract] [Full Text] [Related]
13. US authorities uphold suspension of SCID gene therapy.
Fox JL
Nat Biotechnol; 2003 Mar; 21(3):217. PubMed ID: 12610555
[No Abstract] [Full Text] [Related]
14. Scrutiny of gene therapy broadens, intensifies.
Fox JL
Nat Biotechnol; 2000 Apr; 18(4):377. PubMed ID: 10748511
[No Abstract] [Full Text] [Related]
15. Gene therapy on trial.
Marshall E
Science; 2000 May; 288(5468):951-7. PubMed ID: 10841710
[No Abstract] [Full Text] [Related]
16. Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector.
Podsakoff GM
Mol Ther; 2001 Oct; 4(4):282-3. PubMed ID: 11592827
[No Abstract] [Full Text] [Related]
17. US plans to protect clinical research participants.
Fox JL
Nat Biotechnol; 2000 Jul; 18(7):709. PubMed ID: 10888829
[No Abstract] [Full Text] [Related]
18. The increasing opacity of gene therapy.
Nature; 1999 Nov; 402(6758):107. PubMed ID: 10646989
[No Abstract] [Full Text] [Related]
19. Gene therapy for rare diseases.
Nat Genet; 1999 Aug; 22(4):313-4. PubMed ID: 10431225
[No Abstract] [Full Text] [Related]
20. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
Couzin J; Kaiser J
Science; 2005 Feb; 307(5712):1028. PubMed ID: 15718439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
